Usmj Etf: A Guide To Investing In The Cannabis Industry

The Evolve US Marijuana ETF (USMJ) is a Canadian-based fund that invests in the US cannabis industry. The fund, which is traded on the NEO exchange, was launched in April 2019 and is the first ETF to focus on the US cannabis market. USMJ is an actively managed fund that provides investors with a flexible, opportunistic, selective, and responsive portfolio. The ETF includes 38 cannabis companies operating in the US, with a focus on those with a market cap of at least $100 million. While legalization in the US is still evolving at the state and federal levels, the fund seeks to capitalize on the rapid development of the market and the potential for the US to become the largest market globally once legalization occurs at the federal level.

USMJ ETF's top holdings

The Evolve ETF's US Marijuana ETF (USMJ) is a flexible, opportunistic, selective, and responsive investment option for those looking to capitalise on the rapidly developing cannabis industry in the US. While the legalisation of cannabis in the United States is still evolving at the state and federal levels, investors can take advantage of short-term catalysts to benefit from the market's swift expansion.

USMJ's top holdings include:

• Green Thumb Industries (5.39%)
• Cresco Labs (5.26%)
• Canopy Growth (4.98%)
• Harvest Health & Recreation (4.83%)
• Charlotte's Web Holdings (4.57%)
• Terrascend (2.08%)

These top holdings make up 43.86% of USMJ's total assets, with the ETF claiming to have 39 holdings in total.

USMJ is not the only ETF focused on the cannabis industry. Others include Horzion ETF's US Marijuana Index ETF (HMUS) and AdvisorShares' Pure Cannabis ETF (YOLO). However, USMJ stands out by focusing on US-based operators, aiming to capitalise on the significant opportunity in the world's largest economy.

With the USMJ ETF, investors can benefit from the flexibility and responsiveness of the fund, which can quickly reposition its portfolio based on regulatory news and market developments. This adaptability is crucial in an emerging industry like cannabis, where legalisation status can significantly impact investment prospects.

USMJ ETF's portfolio

The Evolve US Marijuana ETF (USMJ) is a flexible, opportunistic, selective, and responsive ETF that provides investors with exposure to the US cannabis market. It is designed to capitalise on the rapid development of the market as individual states legalise cannabis, with the potential for further growth if it is legalised at a federal level.

USMJ is an actively managed ETF, which is particularly important in the cannabis sector due to the impact of news, corporate mergers and acquisitions, and regulatory changes. Evolve's active management approach involves making tactical shifts in the portfolio whenever necessary, rather than rebalancing on a set schedule. The ETF also prioritises liquidity, avoiding positions that would be difficult to liquidate.

USMJ's top holdings as of April 2019 included Curaleaf Holdings Inc, Green Thumb Industries Inc, Cresco Labs Inc, Canopy Growth Corp, and Harvest Health & Recreation Inc. The ETF requires a minimum market cap of $100 million for its holdings, which consist of 38 cannabis companies operating in the US.

USMJ is traded on the NEO exchange and was launched by Evolve Funds Group, which also manages the Marijuana ETF (SEED) on the Toronto Stock Exchange.

USMJ ETF's active management approach

The Evolve U.S. Marijuana ETF (USMJ) is an actively managed fund that provides investors with exposure to the U.S. cannabis market. This market is rapidly developing due to short-term catalysts, even as legalization in the United States is still a work in progress at the state and federal levels. The fund's active management approach is designed to navigate this dynamic landscape and capitalize on emerging opportunities.

USMJ's active management approach is characterized by its flexibility, opportunism, selectiveness, and responsiveness. The fund's portfolio is actively managed and diversified, allowing for opportunistic repositioning as market conditions evolve. This strategy enables the fund to be selective in its stock choices, basing decisions on fundamental analysis and risk management considerations.

A key aspect of USMJ's active management is its ability to make tactical shifts in the portfolio whenever necessary. Unlike traditional rebalancing, which follows a set schedule, USMJ's approach is more dynamic and responsive to market developments. This strategy allows the fund to adapt to the fast-paced and news-driven nature of the cannabis sector, where corporate M&A activity and regulatory changes can significantly impact individual companies' performance.

The fund's management team closely monitors the market and takes action when warranted, ensuring liquidity in their positions. This proactive approach is designed to capitalize on emerging opportunities and mitigate potential risks. USMJ's active management strategy is a key differentiator, especially in the cannabis sector, where the dispersion in returns between successful and underperforming companies can be significant.

The fund's top holdings include prominent cannabis companies such as Curaleaf Holdings Inc, Green Thumb Industries Inc, Cresco Labs Inc, Canopy Growth Corp, and Harvest Health & Recreation Inc. These companies are carefully selected and monitored by the management team to ensure they align with the fund's investment objectives and risk parameters.

USMJ ETF's market performance

The Evolve US Marijuana ETF (USMJ) is an actively managed, diversified mix of equities that focuses on US companies. It offers investors a flexible, opportunistic, selective, and responsive portfolio. The ETF's performance is closely tied to the legalisation of cannabis in the United States, which is rapidly developing due to short-term catalysts at the state and federal levels.

USMJ's performance is promising due to its ability to quickly reposition the portfolio and capitalise on recent events and regulatory news. The ETF's track record demonstrates its ability to seize opportunities in the rapidly growing cannabis industry.

USMJ's holdings include prominent cannabis companies such as Green Thumb Industries, Cresco Labs, Canopy Growth, Harvest Health & Recreation, and Charlotte's Web Holdings. These companies are well-positioned to benefit from the expanding legal cannabis market in the United States.

While the ETF currently focuses on US companies, it is important to note that the legal status of cannabis in the country is still evolving. The market performance of USMJ is closely tied to the progression of legalisation, and full legalisation at the federal level will likely have a significant impact on the ETF's performance and the overall cannabis industry.

Overall, USMJ presents an attractive investment opportunity for those seeking exposure to the rapidly developing cannabis industry in the United States. The ETF's ability to adapt to market changes and its diverse holdings contribute to its strong market performance.

USMJ ETF's issuer

Evolve ETFs is the issuer of USMJ, an ETF that focuses on U.S. companies in the cannabis industry. Evolve ETFs is a Canadian investment firm that specializes in providing innovative and disruptive investment solutions. The firm has a range of exchange-traded funds (ETFs) that offer investors exposure to various sectors and themes, including disruptive innovation, healthcare, technology, and financial services.

USMJ, or the U.S. Marijuana ETF, is one of Evolve ETFs' offerings that provides investors with a flexible, opportunistic, selective, and responsive portfolio. This ETF actively manages a diversified mix of equities in the U.S. cannabis industry, allowing investors to capitalize on the rapidly developing market. The legalization of cannabis in the United States at the federal level is expected to position the country as the largest market globally.

USMJ's portfolio includes holdings in several prominent cannabis companies, such as Green Thumb Industries, Cresco Labs, Canopy Growth, and Harvest Health & Recreation. The ETF aims to provide investors with exposure to the growing cannabis industry in the United States, offering the potential for significant returns as the market expands.

Investing in USMJ, like any other ETF, comes with certain risks and considerations. Commissions, management fees, and expenses are associated with ETFs, and investors should carefully read the prospectus before investing. The value of ETFs can fluctuate, and past performance does not guarantee future results. Additionally, investors should be aware of the regulatory environment surrounding the cannabis industry, which can impact the performance of related ETFs.

Frequently asked questions